Topical mTOR (mechanistic target of rapamycin) inhibitor therapy in facial angiofibroma.
Samanta D. Topical mTOR (mechanistic target of rapamycin) inhibitor therapy in facial angiofibroma. Indian J Dermatol Venereol Leprol. 2015 Sep-Oct; 81(5):540-1.